Step 4: Monitor your energy and recovery
Highlights: GLP-1 receptor agonists linked to 14 percent lower risk of developing substance use disorders Reduced risks observed across alcohol, cannabis, cocaine, nicotine and opioid disorders Patients with existing addiction experienced fewer overdoses, hospitalizations and deaths GLP-1 receptor agonist drugs commonly prescribed for type 2 diabetes mellitus and obesity may also be linked to lower risk of substance use disorders (SUD) , according to a large cohort study published in the journal BMJ (1 Trusted Source Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
The SSRIs: advantages, disadvantages and differences
[1] [4] Administered as a once-weekly subcutaneous injection, it works by mimicking the action of the naturally occurring hormone GLP-1, which plays a crucial role in glucose regulation and appetite control
We know you might have questions along the way
What does a complete medical evaluation for Tirzepatide treatment involve